Nader Z. Pourhassan
2017
In 2017, Nader Z. Pourhassan earned a total compensation of $1.1M as President and Chief Executive Officer at CytoDyn, a 14% decrease compared to previous year.
Compensation breakdown
| Bonus | $252,750 |
|---|---|
| Option Awards | $456,660 |
| Salary | $421,250 |
| Other | $12,638 |
| Total | $1,143,298 |
Pourhassan received $456.7K in option awards, accounting for 40% of the total pay in 2017.
Pourhassan also received $252.8K in bonus, $421.3K in salary and $12.6K in other compensation.
Rankings
In 2017, Nader Z. Pourhassan's compensation ranked 8,336th out of 14,666 executives tracked by ExecPay. In other words, Pourhassan earned more than 43.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,336 out of 14,666 | 43rd |
Division Manufacturing | 3,162 out of 5,772 | 45th |
Major group Chemicals And Allied Products | 1,048 out of 2,075 | 50th |
Industry group Drugs | 825 out of 1,731 | 52nd |
Industry Pharmaceutical Preparations | 644 out of 1,333 | 52nd |
Source: SEC filing on July 24, 2017.
Pourhassan's colleagues
We found two more compensation records of executives who worked with Nader Z. Pourhassan at CytoDyn in 2017.